Web Analytics



Home Tags Posts tagged with "Zhou Hanshuo"

Tag: Zhou Hanshuo

Firms advise on Insilico Medicine’s HKD2.28bn HKEX IPO

AI drug discovery firm Insilico Medicine listed on the HKEX main board on 30 December 2025

Cross-border medical data compliance in new era of regulation

By Zhou Hanshuo, Jingtian & Gongcheng

Biosafety Law: China’s new, stricter controls

By Zhou Hanshuo and Wang Xiaoyun, Jingtian & Gongcheng

Three questions on medical data compliance

By Zhou Hanshuo and Yuan Lizhi, Jingtian & Gongcheng

MOST READ ON LAW.ASIA

Correspondents

SEC and the cost of local capital market investment

SEC and the cost of local capital market investment

By Luke Morgan B Codilla, ACCRALAW
Arbitration Clause Drafting

Consent, clarity and arbitration clause lessons

By Hiral Gupta and Surabhi Sharan, Bharucha & Partners
India Green Channel Route

Green Channel Route: Gains and predictability

By Vandana Pai and Hardik Dave, Bharucha & Partners
Impact Investing Compliancevideo

Impact investing: Do use of proceeds clauses actually work?

By Mita Sood, Bharucha & Partners

Follow us on LinkedIn

Follow now